Cloned Antibodies as Treatment Avenue

Coronavirus News

Mount Sinai Health System and the pharmaceutical company Sorrento Therapeutics have partnered together for an exciting project. Mount Sinia is supplying blood samples from 15,000 coronavirus patients for Sorrento to identify antibodies and develop a cloning mechanism to mass-produce them. The hope is to produce a three antibody cocktail that is easily scalable and offers protection against a changing virus.

Doctors are cloning COVID patients’ antibodies for new treatment

To develop a preventative treatment for the coronavirus, doctors are enlisting thousands of patients who have already recovered. Or, more specifically, they’re enlisting the coveted antibodies that those patients’ immune systems generated in response to the virus.

Leave a Reply

Your email address will not be published. Required fields are marked *